A Game-Changer in HIV Prevention: Lenacapavir Promises Hope, But at What Cost?
In a bold leap forward for HIV prevention, a new injectable drug named Lenacapavir is reshaping the way the world approaches protection. Developed by Gilead Sciences and marketed as Sunlenca, Lenacapavir is a revolutionary treatment that requires just two injections…
